This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Molecure S.a.. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Marcin Zakrzewski: Innovator in Pharmaceutical Synthesis
Introduction
Marcin Zakrzewski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical synthesis, holding a total of 2 patents. His work focuses on innovative processes that enhance the production of complex chemical compounds.
Latest Patents
Zakrzewski's latest patents include a process for the production of 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methyl-morpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine. This invention relates to the synthesis of this compound in two hydrated crystalline forms and one anhydrous crystalline form. Additionally, it involves methyl (Z)-4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)-N-cyanopiperidine-1-carbimidothioate, which serves as an intermediate in the synthesis process.
Career Highlights
Marcin Zakrzewski is currently associated with Molecure S.A., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in chemical synthesis has positioned him as a key player in his field.
Collaborations
He collaborates with talented professionals such as Grzegorz Witkowski and Marta Magdycz, contributing to a dynamic and innovative work environment.
Conclusion
Marcin Zakrzewski's contributions to pharmaceutical synthesis through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in chemical processes.